Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with erlotinib in patients with advanced solid tumors
Crossref DOI link: https://doi.org/10.1007/s00280-015-2883-8
Published Online: 2015-09-29
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tolcher, Anthony W.
LoRusso, Patricia
Arzt, Jennifer
Busman, Todd A.
Lian, Guinan
Rudersdorf, Niki S.
Vanderwal, Carol Ann
Kirschbrown, Whitney
Holen, Kyle D.
Rosen, Lee S.
Funding for this research was provided by:
Genentech
AbbVie Inc
Text and Data Mining valid from 2015-09-29